Contract research organisation WCCT Global says its newly-launched patient recruitment service could have particular application in orphan drug trials.
The California, US-based CRO’s new In-Site programme uses digital technology to locate patient groups and determine the best sites to conduct the clinical trial.
WCCT says patient recruitment is often as much of a challenge as the technical and commercial hurdles orphan drugs face, if not more so.
WCCT Global’s chief operating officer Jon Rojas said: “We have established our specialised recruitment method which is uniquely applicable to the recruitment issues faced by sponsors that are developing orphan drugs. We point this out because we feel there is a need in the clinical research industry that must to be filled.”
The In-Site patient recruitment tool focuses on identifying patients that could best fit a particular trial to increase the efficiency of the process.
The new programme also includes an “advanced digital advertising process”. This entails creating an “in-depth psychographic” based on the orphan indication and then targeting digital and social media outlets in order to ensure patient access.
